Cargando…

Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications

Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease with insulin deficiency due to pancreatic β cell destruction. Multiple independent cohort studies revealed specific lipid spectrum alterations prior to islet autoimmunity in T1DM. Except for serving as building blocks for membrane bioge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Xiao, Yang, Hu, Jingyi, Liu, Shanshan, Zhou, Zhiguang, Xie, Lingxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583919/ https://www.ncbi.nlm.nih.gov/pubmed/36275658 http://dx.doi.org/10.3389/fimmu.2022.999108

Ejemplares similares

The role of inflammation in immune system of diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications
por: Yue, Tong, et al.
Publicado: (2022)

Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches
por: Fisicaro, Paola, et al.
Publicado: (2020)

Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options
por: Salvatore, Teresa, et al.
Publicado: (2022)

Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity
por: Mondanelli, Giada, et al.
Publicado: (2021)

Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications
por: Börgeson, Emma, et al.
Publicado: (2012)

Pathogenetic Therapy of Psoriasis by Muramyl Peptide
por: Guryanova, Svetlana, et al.
Publicado: (2019)

Plasma-derived exosomal mRNA profiles associated with type 1 diabetes mellitus
por: Fan, Wenqi, et al.
Publicado: (2022)

Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to Correction
por: Darenskaya, M. A., et al.
Publicado: (2021)

Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications
por: Kang, Qingzheng, et al.
Publicado: (2020)

Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy
por: Hu, Jingyi, et al.
Publicado: (2022)

The m6A methylation profiles of immune cells in type 1 diabetes mellitus
por: Wang, Yimeng, et al.
Publicado: (2022)

Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
por: Galiero, Raffaele, et al.
Publicado: (2023)

T-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications
por: Fozza, Claudio, et al.
Publicado: (2011)

The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications
por: Marinoni, Beatrice, et al.
Publicado: (2014)

The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
por: Daryabor, Gholamreza, et al.
Publicado: (2020)

COVID-19 as an Immune Complex Hypersensitivity in Antigen Excess Conditions: Theoretical Pathogenetic Process and Suggestions for Potential Therapeutic Interventions
por: Manzo, Giovanni
Publicado: (2020)

The RASopathies: from pathogenetics to therapeutics
por: Hebron, Katie E., et al.
Publicado: (2022)

Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides
por: Lamprecht, Peter, et al.
Publicado: (2018)

Vascular endotheliitis associated with infections: Its pathogenetic role and therapeutic implication
por: Hattori, Yuichi, et al.
Publicado: (2022)

Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis
por: Liu, Yanli, et al.
Publicado: (2013)

Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases
por: Li, Xuan, et al.
Publicado: (2017)

Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies
por: Heming, Michael, et al.
Publicado: (2019)

Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells
por: Melissaropoulos, Konstantinos, et al.
Publicado: (2022)

Chemokines in Type 1 Diabetes Mellitus
por: Pan, Xiongfeng, et al.
Publicado: (2022)

DRUGGABLE MM THERAPEUTICS: PATHOGENETIC PATHWAYS
por: Ocio, Enrique M
Publicado: (2022)

Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
por: Campa, Claudio, et al.
Publicado: (2010)

Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
por: Potere, Nicola, et al.
Publicado: (2022)

Prevalence of Autoimmune and Autoinflammatory Diseases in Chronic Urticaria: Pathogenetic, Diagnostic and Therapeutic Implications
por: Murdaca, Giuseppe, et al.
Publicado: (2023)

Transcriptional Regulation of T-Cell Lipid Metabolism: Implications for Plasma Membrane Lipid Rafts and T-Cell Function
por: Robinson, George A., et al.
Publicado: (2017)

DNA methylation in diabetic retinopathy: pathogenetic role and potential therapeutic targets
por: Cai, Chunyang, et al.
Publicado: (2022)

Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions
por: Huo, Jin-Ling, et al.
Publicado: (2023)

Identification of Common Pathogenetic Processes between Schizophrenia and Diabetes Mellitus by Systems Biology Analysis
por: Rahman, Md Rezanur, et al.
Publicado: (2021)

Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?
por: Bruni, Cosimo, et al.
Publicado: (2018)

Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association?
por: Maglie, Roberto, et al.
Publicado: (2022)

Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach
por: Lu, Lu, et al.
Publicado: (2022)

Identification of hsa_circRNA_100632 as a novel molecular biomarker for fulminant type 1 diabetes
por: Yin, Wenfeng, et al.
Publicado: (2023)

Identification of Sorafenib as a Treatment for Type 1 Diabetes
por: Zeng, Qin, et al.
Publicado: (2022)

New Developments in T Cell Immunometabolism and Therapeutic Implications for Type 1 Diabetes
por: Zhang, Mengdi, et al.
Publicado: (2022)

IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications
por: Iznardo, Helena, et al.
Publicado: (2022)

The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus
por: Liu, Ling-Bin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6lsvaah3gef0dren5iq0olr79r